Catalyst Wire Dossier Catalyst Wire Dossier

AR-13324 ophthalmic solution

netarsudil · Aerie Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AR-13324 ophthalmic solution, covering 2018-04-13 to 2018-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]

See pricing